T-Cell Immune Surveillance in Allogenic Stem Cell Transplant Recipients: Are Whole Blood–Based Assays Ready to Challenge ELISPOT?
2020; Oxford University Press; Volume: 8; Issue: 1 Linguagem: Inglês
10.1093/ofid/ofaa547
ISSN2328-8957
AutoresChris D. Lauruschkat, Lukas Page, Sonja Etter, Philipp Weis, Florian Gamon, Sabrina Kraus, Hermann Einsele, Sebastian Wurster, Juergen Loeffler,
Tópico(s)Fungal Infections and Studies
ResumoAbstract We compared the feasibility of 4 cytomegalovirus (CMV)- and Aspergillus-reactive T-cell immunoassay protocols in allogenic stem cell transplant recipients. While enzyme-linked immunospot performed best overall, logistically advantageous whole blood–based assays performed comparably in patients with less severe lymphocytopenia. CMV-induced interferon-gamma responses correlated strongly across all protocols and showed high concordance with serology.
Referência(s)